NIH VideoCast - Workshop on Systemic Immunogenicity Considerations for Adeno-Associated Virus (AAV)-Mediated Gene Therapy (Day 1)

Skip Navigation

Workshop on Systemic Immunogenicity Considerations for Adeno-Associated Virus (AAV)-Mediated Gene Therapy (Day 1)

Loading... Loading video...

3,685 Views

Air date:	Monday, November 30, 2020, 9:30:00 AM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 3,685 (2,034 Live, 1,651 On-demand)
Category:	Conferences
Runtime:	06:22:40
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) and the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) are co-hosting a virtual Workshop on Systemic Immunogenicity Considerations for Adeno-Associated Virus (AAV)-Mediated Gene Therapy. This meeting will bring together scientists, therapeutic developers and patient representatives to focus on immunogenicity issues related to the systemic administration of AAV gene therapy products and identify solutions for those issues. For more information go to https://events-support.com/events/NCATS_Gene_Therapies_November_2020

NLM Title:	Workshop on Systemic Immunogenicity Considerations for Adeno-Associated Virus (AAV)-Mediated Gene Therapy / National Center for Advancing Translational Sciences, NIH, Center for Biologics Evaluation and Research, FDA.
Author:	Workshop on Systemic Immunogenicity Considerations for Adeno-Associated Virus (AAV)-Mediated Gene Therapy National Center for Advancing Translational Sciences (U.S.), Center for Biologics Evaluation and Research (U.S.),
Publisher:
Abstract:	(CIT): The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) and the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) are co-hosting a virtual Workshop on Systemic Immunogenicity Considerations for Adeno-Associated Virus (AAV)-Mediated Gene Therapy. This meeting will bring together scientists, therapeutic developers and patient representatives to focus on immunogenicity issues related to the systemic administration of AAV gene therapy products and identify solutions for those issues.
Subjects:	Dependovirus--genetics Dependovirus--immunology Genetic Therapy
Publication Types:	Congress Webcast

NLM Classification:	QW 165.5.P3
NLM ID:	101774305
CIT Live ID:	38547
Permanent link:	https://videocast.nih.gov/watch=38547

Related Videos...